The role of the novel D2/β2-agonist, Viozan™ (sibenadet HCl), in the treatment of symptoms of chronic obstructive pulmonary disease: results of a large-scale clinical investigation - Concepedia

Concepedia

Publication | Closed Access

The role of the novel D2/β2-agonist, Viozan™ (sibenadet HCl), in the treatment of symptoms of chronic obstructive pulmonary disease: results of a large-scale clinical investigation

23

Citations

11

References

2003

Year

L. C. Laursen, Ari Lindqvist, Trish Hepburn, Julie Lloyd, John Perrett, N. Sanders, K. Rocchiccioli

Respiratory Medicine

MedicinePulmonary PharmacologyPulmonary MedicinePharmacotherapySibenadet HclPharmacologyPulmonary DiseaseNovel D2/β2-agonistLarge-scale Clinical Investigation

References

	Year	Citations

Page 1